Items related to Glutamate and Neuropsychiatric Disorders: Current and...

Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments - Softcover

 
9783030874827: Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments
  • PublisherSpringer
  • Publication date2023
  • ISBN 10 3030874826
  • ISBN 13 9783030874827
  • BindingPaperback
  • Edition number1
  • Number of pages635
  • EditorPavlovic Zoran M.

Buy Used

Condition: As New
Unread book in perfect condition... Learn more about this copy

Shipping: US$ 2.64
Within U.S.A.

Destination, rates & speeds

Add to basket

Top Search Results from the AbeBooks Marketplace

Seller Image

Pavlovic, Zoran M. (EDT)
Published by Springer, 2023
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Softcover

Seller: GreatBookPrices, Columbia, MD, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # 45845462-n

Contact seller

Buy New

US$ 285.26
Convert currency
Shipping: US$ 2.64
Within U.S.A.
Destination, rates & speeds

Quantity: 5 available

Add to basket

Seller Image

Published by Springer, 2023
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Soft Cover

Seller: booksXpress, Bayonne, NJ, U.S.A.

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

Soft Cover. Condition: new. Seller Inventory # 9783030874827

Contact seller

Buy New

US$ 287.91
Convert currency
Shipping: FREE
Within U.S.A.
Destination, rates & speeds

Quantity: 3 available

Add to basket

Seller Image

ISBN 10: 3030874826 ISBN 13: 9783030874827
New Kartoniert / Broschiert
Print on Demand

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Kartoniert / Broschiert. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reviews the interplay of the glutamatergic system with other neurotransmitters & neurotrophic factors in CNS diseasesIndividual chapters deal with the neuropathophysiology and glutamate-based treatment options of a specific CNS diseasePrese. Seller Inventory # 838234206

Contact seller

Buy New

US$ 236.63
Convert currency
Shipping: US$ 54.53
From Germany to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Stock Image

Published by Springer, 2023
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Softcover

Seller: Ria Christie Collections, Uxbridge, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. In. Seller Inventory # ria9783030874827_new

Contact seller

Buy New

US$ 279.72
Convert currency
Shipping: US$ 13.29
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Stock Image

Zoran M. Pavlovic
Published by Springer, 2023
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Softcover
Print on Demand

Seller: Ria Christie Collections, Uxbridge, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783030874827_lsuk

Contact seller

Buy New

US$ 279.72
Convert currency
Shipping: US$ 13.29
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Zoran M. Pavlovic
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Paperback First Edition

Seller: Grand Eagle Retail, Wilmington, DE, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Paperback. Condition: new. Paperback. This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development.In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD), Alzheimers Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinsons Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines. The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence.Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9783030874827

Contact seller

Buy New

US$ 297.99
Convert currency
Shipping: FREE
Within U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket

Seller Image

Pavlovic, Zoran M. (EDT)
Published by Springer, 2023
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Softcover

Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # 45845462-n

Contact seller

Buy New

US$ 279.70
Convert currency
Shipping: US$ 19.97
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: 5 available

Add to basket

Seller Image

Zoran M. Pavlovic
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Taschenbuch
Print on Demand

Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development.In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD),Alzheimer's Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinson's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines.The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence.Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs. 636 pp. Englisch. Seller Inventory # 9783030874827

Contact seller

Buy New

US$ 282.13
Convert currency
Shipping: US$ 25.60
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Seller Image

Pavlovic, Zoran M. (EDT)
Published by Springer, 2023
ISBN 10: 3030874826 ISBN 13: 9783030874827
Used Softcover

Seller: GreatBookPrices, Columbia, MD, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: As New. Unread book in perfect condition. Seller Inventory # 45845462

Contact seller

Buy Used

US$ 308.35
Convert currency
Shipping: US$ 2.64
Within U.S.A.
Destination, rates & speeds

Quantity: 5 available

Add to basket

Seller Image

Zoran M. Pavlovic
ISBN 10: 3030874826 ISBN 13: 9783030874827
New Taschenbuch

Seller: AHA-BUCH GmbH, Einbeck, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development.In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD),Alzheimer's Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinson's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines.The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence.Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs. Seller Inventory # 9783030874827

Contact seller

Buy New

US$ 282.13
Convert currency
Shipping: US$ 36.72
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket

There are 5 more copies of this book

View all search results for this book